Nasopharyngeal carcinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Faizan}} | {{CMG}} {{AE}}{{Faizan}} | ||
==Overview== | ==Overview== | ||
The mainstay of therapy for nasopharyngeal carcinoma is external beam [[radiotherapy]], supplemented in some cases with [[chemotherapy]]. | |||
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy, supplemented in some cases with chemotherapy. | |||
==Medical Therapy== | ==Medical Therapy== | ||
*Standard treatments for patients with nasopharyngeal carcinoma include: | |||
**Radiation therapy alone | |||
**Concurrent [[chemoradiation]] followed by adjuvant chemotherapy | |||
**Chemotherapy alone for m[[etastatic]] disease | |||
Standard treatments for patients with nasopharyngeal | |||
* | *Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following: | ||
* | **Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost | ||
* | **Brachytherapy | ||
Undifferentiated subtype of NPC is highly radiosensitive.<ref name="Weidner's">{{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}</ref> | |||
==References== | ==References== | ||
Revision as of 18:14, 16 September 2015
|
Nasopharyngeal carcinoma Microchapters |
|
Differentiating Nasopharyngeal carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Nasopharyngeal carcinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Nasopharyngeal carcinoma medical therapy |
|
Risk calculators and risk factors for Nasopharyngeal carcinoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
The mainstay of therapy for nasopharyngeal carcinoma is external beam radiotherapy, supplemented in some cases with chemotherapy.
Medical Therapy
- Standard treatments for patients with nasopharyngeal carcinoma include:
- Radiation therapy alone
- Concurrent chemoradiation followed by adjuvant chemotherapy
- Chemotherapy alone for metastatic disease
- Treatments under clinical evaluation for patients with nasopharyngeal cancer include the following:
- Dose escalation with new radiation therapy techniques such as stereotactic radiation therapy boost
- Brachytherapy
Undifferentiated subtype of NPC is highly radiosensitive.[1]
References
- ↑ {{cite book |author=Richard Cote, Saul Suster, Lawrence Weiss, Noel Weidner (Editor) |title=Modern Surgical Pathology (2 Volume Set) |publisher=W B Saunders |location=London |year= |pages= |isbn=0-7216-7253-1 |oclc= |doi=}